Document:

ex10-1.htm

    EXHIBIT
10.1

     

     

    
      October
11, 2007

      

      Mr. David
Kaput

      20
Carrigan Avenue

      White
Plains, NY 10615-4645

      

      Dear
David:

       

      On behalf
of ACCO Brands Corporation, I am very pleased to confirm our offer to you for
the position of Senior Vice President, Chief Human Resources Officer reporting
directly to David Campbell, our Chief Executive Officer. Your start date will be
Monday, October 15th, 2007.

      

      Your
bi-weekly base salary will be $11,538.46, which is $300,000 annualized. You will
participate in our annual Management Incentive Plan (MIP) with a target award of
50% of your base salary. Actual awards will range from 0% to 200% of target
depending upon company performance standards established by our Board's
Compensation Committee. For 2007, your participation in the MIP will be
pro-rated to your start date and will be guaranteed to pay out at target. For
2008, your participation will be guaranteed to pay out minimally at target
performance.

      

      You will
also be enrolled in the Executive Auto Allowance Program. Your benefit under
this plan will be $538.15, which is currently $13,992 annualized.

      

      You will
also be eligible to participate in ACCO Brands Long Term Incentive Plan (LTIP)
beginning with awards that may be made in early 2008. The plan is a 4-year
rolling plan, with annual grants. Rewards may consist of equity-based awards
and/or cash awards. The value of your initial grant will be commensurate with
those awarded to your peers and as determined by the Board's Compensation
Committee. (For the 2007 plan year, the combination of performance stock units,
restricted stock units, and stock options for this level of position had an
estimated value of $240,000 at target.) Plan details will be provided at the
time of your first grant.

      

      As an
ACCO Brands employee you will also be eligible to participate in our health,
welfare, and retirement benefit programs, including term life insurance at two
times base salary. Materials outlining these programs are also
enclosed.

      

      We
understand that you will be relocating from New York to Chicago. To assist you
in your move, you are eligible for the executive benefits described in the
Relocation Program materials included with this letter. You will have until
August of 2008 to initiate your benefits under this plan. During the interim
period, ACCO Brands will cover reasonable travel and temporary housing expenses.
Please note these benefits are provided only upon the condition that you will
pay ACCO Brands on demand its out-of-pocket expenses incurred in connection with
your relocation in the event you voluntarily terminate your employment within
one (1) year of your start date. Should you voluntarily terminate your
employment within the second year of your employment, one-half (1/2) of those
out-of-pocket expenses would need to be repaid to ACCO Brands.

      

      This
offer is contingent upon a satisfactory background check and drug screen results
as well as confirmation of your eligibility to work in the United States. You
must submit to a drug test within 3 days of receipt of this letter. Please refer
to the enclosed Drug Testing Procedure for specifics - no advance appointment is
necessary.

      

      
        
           

        

        
          Page 1 of
2

          
            

          

        

        
           

        

      

      This
letter is not intended to constitute a contract of employment. Employment with
ACCO Brands Corporation is "at will" and subject to termination by you or the
company at any time, with or without cause or prior notice. Nothing in this
letter or in any of the accompanying materials alters this at-will
relationship.

      

      David, we
believe this is an exceptional offer package and are confident that ACCO Brands
can offer you the chance to build a rewarding career. We are delighted to have
the opportunity to extend this offer and look forward to you joining
us.

      

      Prior to
your first day of employment, please complete the enclosed forms in the New Hire
Packet and bring them with you on your start date. You must also provide
documentation of your legal right to work in the United States. If you have
specific questions regarding this, please contact me directly at (847)
484-3800.

      

      Please
acknowledge your acceptance of this offer and understanding of its contents and
indicate by returning one signed copy of this letter in the enclosed envelope
within 3 business days; you may
keep the second copy for your personal records. If you have questions on this,
please feel free to contact me. Thank you.

      

      Sincerely,

      

      

      /s/ Sam H. Wheeler 

      

      Sam H.
Wheeler

      Vice
President, Human Resources

      ACCO
Brands Corporation

      

      

      

      

      
        
          
            
              	
                      Accepted
      By:

                    	 
      /s/ David Kaput	
                       

                    	 
      

            

          

        

      

      

      Enclosures

      
        	
                cc:

              	
                Steve
      Rubin

              

      

      
        	
                 
      

              	
                Irma
      Long

              

      

      
        	
                 
      

              	
                Margaret
      Lichtenstein

              

      

       

       

      
        
          
          

        

        
          Page 2 of
2exv10w5

EXHIBIT
10.5

FORM OF AMENDMENT ONE TO

NONSTATUTORY STOCK OPTION AGREEMENT

[Insert Option(s) Grant Date(s)/Options granted under the 2004 Equity Incentive Plan pursuant to the Non-Employee Director Compensation Program]

Dear [Insert Grantee Name]:

     
Effective this date, Anadys Pharmaceuticals, Inc. (the “Company”) has amended the
Nonstatuory Stock Option(s) identified above (the “Option(s)”), which was (were) granted
to you under the Company’s 2004 Equity Incentive Plan (the “EIP”).  The changes to the terms
 of the Option(s) contained in this Amendment One were approved by the Board of Directors on
 March 25, 2008 and are made to conform the Option(s) granted to you under the EIP in your
 capacity as a Non-Employee Director to certain provisions contained within the Non-Employee
Director Stock Option Plan (the “Plan”).

     
The changes to the terms of the Option(s) are mutually agreed to by you and the Company and
 are set forth below, with such defined terms as set forth in the Plan:

	1.	 	 A new Section 11 entitled “Change in Control” is added after Section 10 of the
Nonstatutory Stock Option Agreement(s) to read as follows:

     
Upon a Change in Control, the vesting of Options that are held by Optionholders
whose Continuous Service  has not terminated prior to the effective time of the Change in
Control (and, if applicable, the time at which such Options may be exercised) shall
 (contingent upon the effectiveness of the Change in Control) be accelerated in full
to a date prior to the effective time of such Change in Control as the Board shall
determine (or, if the Board shall not determine such a date, to the date that is five
(5) days prior to the effective time of the Change in Control), and such Options shall
 terminate on the date that is twelve (12) months after the effective time of the Change
in Control if not exercised (if applicable) at or prior to date.  With respect to any other
Options outstanding under the Plan, the vesting of such Options (and, if applicable, the time
 at which such Options may be exercised) shall not be accelerated, unless otherwise provided
 in a written agreement between the Company or any Affiliate and the holder of such Options,
and such Options shall terminate if not exercised (if applicable) prior to the effective time
 of the Change in Control.

	2.	 	The section entitled “Notices” of the Nonstatutory Stock Option Agreement is now renumbered as Section 12;
	 
	3.	 	The section entitled “Governing Plan Document” of the Nonstatutory Stock Option Agreement is
now renumbered as Section 13; and

 

 

	4.	 	Except as specifically amended and modified herein, the Option(s) shall continue
 in force and effect pursuant to its terms, as originally granted, subject to the provisions
 of the EIP.

Very truly yours,

	 	 	 	 	 
	Anadys Pharmaceuticals, Inc.

 	 	 
	By:  	
 	 	 
	 	Name:  	Stephen T. Worland, Ph.D 	 	 
	 	Title:  	President and Chief Executive Officer 	 	 
	 

     The undersigned Grantee acknowledges receipt of the foregoing Amendment and understands and agrees that the rights and liabilities with respect to the Option(s) described therein are now contained in the Option and this Amendment One.  

Grantee

	 	 	 	 	 
	By:  	
 	 	Date: 
	 	Name:exhibit10_14.htm

    
      

      

    

     

    
 

    Exhibit
10.14

    

    FIRST
AMENDMENT

    TO

    LICENSE
AGREEMENT

    

    

    THIS FIRST AMENDMENT (the “Amendment”),
made effective this 6th day of
June, 2007 to that certain License Agreement by and between United Western
Bancorp, Inc. (“Licensee”) and Legent Clearing LLC (“Licensor”) dated September
29, 2006 (“Agreement”).

    

    WITNESSETH
THAT:

    

    WHEREAS, the parties hereto have
entered into the Agreement for Licensor to provide to Licensee use of certain
property; and

    

    WHEREAS, Licensor and Licensee desire
to amend the Agreement;

    

    NOW, THEREFORE, in consideration of the
mutual covenants set forth, and other good and valuable consideration, the
receipt and adequacy of which is hereby acknowledged, the parties hereto agree
to amend the Agreement as follows:

    

    
      	
              1.  

            	
              Paragraph
      2. will be deleted and replaced with the attached Paragraph 2. “Term. This
      License will have an initial term from October 1, 2006 to April 30,
      2010.”

            

    

    

    Made and executed this 6th day of
June 2007.

    

    
      	 
      	
              Legent
      Clearing LLC

            
	 
      	
              By: /s/ Frank McPartland

            
	 
      	
              Name:
      Frank McPartland

            
	 
      	
              Title:                      President
      & CEO

            
	 
      	 
      
	 
      	
              United
      Western Bancorp,Inc.

            
	 
      	
              By: /s/ Jamie L. Yancy

            
	 
      	
              Name:  Jamie
      L. Yancy

            
	 
      	
              Title:    Chief
      Technology Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00154-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00154-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00154-of-00352.parquet"}]]